OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

← Chai-Lifeline Cancer Care

2025-03-31-accounts

Charity registration number 1078956 (England and Wales) Company registration number 03640937

CHAI-LIFELINE CANCER CARE

(A COMPANY LIMITED BY GUARANTEE)

ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) LEGAL AND ADMINISTRATIVE INFORMATION

Trustees S. Zuckerbrod L. Hager MBE A. Tookman R. Segal A. Maurice P. Hertz L. Shelley R. Saville Charity number (England and Wales) 1078956 Company number 03640937 Registered office 325-327 Oldfield Lane North Greenford Middlesex UB6 0FX Auditor Landau Morley LLP 325-327 Oldfield Lane North Greenford Middlesex UB6 0FX

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) CONTENTS

Page
Trustees' report 1 - 8
Independent auditor's report 9 - 11
Statement of financial activities 12
Balance sheet 13
Statement of cash flows 14
Notes to the financial statements 15 - 29

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) FOR THE YEAR ENDED 31 MARCH 2025

The Trustees (who are also directors for the purpose of the Companies Act) present their annual report together with the audited financial statements of Chai-Lifeline Cancer Care (the company) for the year ended 31 March 2025.

The Trustees confirm that the Annual report and financial statements of the company comply with the current statutory requirements, have been prepared in accordance with the accounting policies set out in the notes to the financial statements and comply with the charity's governing document, the Companies Act 2006 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)".

Since the company qualifies as small under section 383, the strategic report required of medium and large companies under The Companies Act 2006 (Strategic Report and Director’s Report) Regulations 2013 is not required.

Reference and Administrative Details

Reference and administrative details are shown in the schedule of members of the board and professional advisors on the legal and administrative information page of the financial statements.

Structure, Governance and Management

Chai-Lifeline Cancer Care is a company limited by guarantee governed by its Memorandum and Articles of Association dated 24[th] September 1998 as amended by written resolution on 7[th] August 2012. It has no share capital. It is a registered charity, Charity number 1078956. The charity is governed by the Companies Act 2006 and the Charities Act 2011.

Appointment of Trustees, Induction and Training

Trustees may be recruited from the Jewish Community. They will be able to demonstrate an ability to support, promote and lead development of the charity. They will have an area of expertise that will enhance the work of the Trustees and contribute to the achievement of the charity’s objectives.

New Trustees undergo induction training to brief them on their legal obligations under charity and company law, the content of the Memorandum and Articles of Association, the committee and decision-making processes, the objectives and financial performance of the charity. Trustees are encouraged to attend appropriate external training events where these will facilitate the undertaking of their role.

Organisation

The Board of Trustees administers and determines the general policy of the charity.

In January 2025, CEO Lisa Steele retired after 23 years at Chai, and Victoria Portnoi was appointed by the Trustees in February 2025 as CEO to manage the day-to-day operations of the charity with delegated responsibility.

The vast majority of Chai’s staff provides face to face services for clients.

Related Parties

In the year ended 31[st] March 2025, the charity did not undertake any transactions with related parties other than those disclosed in the financial statements.

Risk Management

The Trustees assess the major risks to which the charity is exposed and implement systems to mitigate both financial and non-financial risks.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

Chai has a risk register which is reviewed regularly. The Trustees also ensure that clinical governance is in place, throughout all service areas of therapy, complementary therapy and counselling, and physical and psychological groups.

Chai operates a high level of confidentiality with respect to all client information.

Achievable fundraising targets are set to cover realistic budgets, which are monitored on a monthly basis together with cash forecasts.

Objectives and Activities

The objectives of the charity are:

To promote the relief of persons suffering from cancer and their families within the Jewish Community and to prevent sickness by promoting good health care and the provision of education and screening programmes for persons within the Jewish community, whether suffering from cancer or not.

The charity has the general aim of providing an extensive range of services including counselling, therapies, complementary therapies, advocacy, legal, financial and spiritual advice, group activities and support groups for the Jewish community.

Chairman’s statement

Chai continues to respond to unprecedented demand across the community.

Chai’s active role in raising awareness of the ground-breaking NHS England Jewish BRCA genetic population testing programme, to identify any person over 18, with at least one Jewish grandparent, for the mutated BRCA1/ BRCA 2 gene, has resulted in 27,918 expressions of interest to be tested.

Chai’s reputation as a leader and innovator in the field of supportive cancer care goes beyond the Jewish Community. We welcomed Labour MP for Hendon, David Pinto-Duschinsky, to our flagship Hendon centre, who then highlighted Chai’s services in a private members’ bill in Parliament. Chai’s contribution to the field of supportive cancer care was further recognised when I was honoured to receive an MBE for services to people with cancer from HRH the Prince of Wales.

The combination of earlier diagnoses and advances in surgery and treatment mean that thankfully more people are living for longer, albeit with physical and emotional changes which affect both the cancer patients and their family members. Our clients often refer to us as the constant factor during a time of great uncertainty in their lives.

To meet the relentless demand, we continue to invest in the infrastructure of the entire organisation, as well as recruiting additional counsellors and therapists. In addition, we have developed more group support, both face to face and online, ensuring greater accessibility to clients who are not close to a Chai centre.

Chai does not receive any statutory funding but was able to continue to provide specialised services mainly through a matched funding campaign which also afforded the opportunity to inform the community of the comprehensive range of support services which Chai provides.

What Chai provides

Chai provides services to the Jewish community, and these can be accessed either by self-referral or referral from a professional.

Chai’s reputation for providing a highly professional service combined with sensitivity and care has encouraged those needing our service to contact us. Services are provided from our flagship centre in Hendon and from our 10 satellite centres across the UK. For those unable to access a Chai site, support is provided through telephone and online counselling, nationally and internationally. Chai serves as a model and blueprint within the supported cancer care world.

Chai services provided to clients are:

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

Many of the support groups are online to allow our clients to join nationally. This has proved particularly beneficial for clients not within geographical reach of a Chai centre.

Objectives for 2024/2025

All objectives were achieved.

Major areas of Fundraising activity

Performance and achievements in 2024/2025

To meet our clients’ many and diverse needs, Chai now provides 70 specialised support services across the nationwide network of 11 satellite centres. For those who cannot come to us, services can be provided in clients’ own homes, hospitals and hospices through our Home Support Services. In addition, clients can still access our expertise and care, including some groups, online.

The feedback from our clients, both the cancer patients and their family members, is that our services make a tangible difference and that this ongoing support brings considerable relief and comfort. Without it, their lives would be of poorer quality as there is nowhere else for them to receive this level of specialised support.

The success of the NHS England Jewish BRCA Testing Programme has continued with 27,918 expressions of interest to receive a testing pack by the end of March 2025. To meet the demand for specialised support for those testing positive for a BRCA mutation, we have increased our BRCA support services for individuals, couples and families.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

Demand for our ‘Chai in Schools’ programme from primary and secondary schools across the UK continues to rise. This is due to the increase in the number of parents being diagnosed with cancer, many of whom have children. In addition to supporting the children during school hours, and in the holidays at a Chai centre, we provide practical advice and strategies to teachers, many of whom have not had experience of dealing with terminal illness.

Service Activity

==> picture [476 x 8] intentionally omitted <==

----- Start of picture text -----
Number of New Clients:
----- End of picture text -----

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

Developing Services

Chai’s Medical Advisory Panel ensures that Chai is kept updated on all developments of cancer treatment and care. This knowledge, together with our clients’ feedback, enables us to refine and plan the range of services that are needed to meet the complex and evolving needs of our clients.

Chai continues to raise awareness of the lifesaving potential of the NHS England Jewish BRCA Testing Programme. With people in the Jewish population six times more likely to carry a mutated gene, Chai’s specialised counsellors receive training from the Royal Marsden and Northwick Park genetics team to enable them to support all those who wish to discuss the implications of being tested as well as those who test positive for a mutated gene.

We have developed an online support group for parents with cancer to provide a reassuring space for them and their partners to voice their feelings and concerns about the impact of cancer on the family unit.

Managing the long-term physical and emotional impact of living with a cancer diagnosis is an on-going challenge for our clients. However, with counsellors providing expert support and with the breadth of our complementary and therapeutic treatments, Chai makes a significant difference to people’s lives.

Fundraising

A matched funding campaign in December was successful in both raising funds and awareness.

Chai’s two annual appeals, Pesach and Rosh Hashana were both successful.

We were able to hold the annual Club 18 Golf Day, Whisky Events in London and Manchester, and the Rosh Hashana Gift Sale.

Quality assurance

A specialist independent consultant reviews all Chai’s policies, and all members of staff receive ongoing cybersecurity awareness training sessions across the UK Chai centres.

The Counsellors’ Handbook and Complementary Therapists’ handbook have both been reviewed and are used across all our sites to clarify processes and to ensure consistency throughout the organisation.

Chai’s Staff Handbook has been updated in line with current legislation.

The Volunteers’ Handbook has been reviewed and is regularly updated.

All further policies are reviewed and constantly updated.

We regularly monitor client feedback and satisfaction levels.

Training for therapists and counsellors, including continued professional development, is provided.

Three external Counselling Supervisors support the Psychological Teams nationally.

The annual Natalie Shipman Memorial Lecture took place in November 2024. Dr Jonathan Sive, a Consultant Haematologist and Clinical Service Lead for myeloma, UCLH and Judy de Winter, Chair of Trustee for the Royal Free charity and president of Myeloma UK, gave a lecture on Influencing Change: One Patient’s Journey to Improve Outcomes.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

Objectives for 2025/2026

Financial review

Donations received from all sources amounted to £4,010,066 (2023/24: £3,819,861) representing a 4.97% increase from last year.

Funds were raised from specific major fundraising and community events, appeals, private donations, legacies, patronage campaigns and commemorative giving.

Chai also received unsolicited donations.

During the year Chai expended:

Cost of providing services - £3,552,349 (2023/24: £3,218,831)

Fundraising and publicity costs - £681,377 (2023/24: £641,054)

Governance costs - £19,619 (2023/24: £18,101)

Annual accounts are delivered to the Charity Commission within 10 months of the financial year-end.

Financial Health

At 31[st] March 2025 there was a net surplus of income for the year of £137,457 (2023/24: £531,775).

Disclosure of Trustee remuneration

See note 10 to the accounts.

Investments

See note 14 to the accounts.

The charity’s wholly owned subsidiary Chai-Lifeline Services Ltd remains dormant. At 31st March 2025, this company’s reserves totalled £2.

The Trustees have adopted a low-risk strategy to the investment of the charity’s funds. The aim of the investment activity is to obtain a reasonable balance between capital growth and income so the charity can meet future demands as well as current needs.

The charity’s investment holdings are currently managed by two independent investment managers, with whom cautious investment mandates have been agreed. The investment managers report on performance and compliance with their mandates on a regular basis to a dedicated Investment Committee. An independent financial adviser assists with the evaluation of the performance of the investment managers and with the asset allocation of the charity’s investments. The Trustees regularly monitor the levels of investments and the returns received to generate sufficient financial return to enable the charity to achieve its objectives effectively and without interruption.

The charity’s investment holdings are diversified by additional holdings in current and short-term cash deposits.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

Volunteers

Chai currently has 120 volunteers who work on behalf of the charity in a variety of roles including befriending, transport, reception duties and administration. The average volunteer spends 2-3 hours a week assisting Chai. All volunteers receive initial training and ongoing supervision.

Reserves Policy

The trustees are committed to meeting the expectations of all clients turning to Chai for support and continue to explore unmet need. No client is turned away and no statutory funding is received.

Our charity supports very sick people and those who are close to them. Our activities include offering educational resources for patients, carers and professionals and our future plans are to proactively explore innovative methods of health promotion with our clientele. In view of the nature of the illness we frequently have a long term commitment with our patients and their families. The Trustees therefore think the charity's reserves policy should reflect this long term engagement and Chai is aiming to build sufficient unrestricted free funds to cover at least one year's future operational costs, for the sake of prudence.

The Trustees have allocated £1m towards an upcoming building project at the Flagship Centre in NW London.

At 31 March 2025 free reserves are £4,191,727 (2024: £2,006,858). The management team continue to put a strong emphasis on building these reserves and have a programme of financial planning to accumulate and sustain these reserves, which will need to increase in line with the finances required to fund the growing number of clients using the services for increasing periods of time.

Trustees

The Trustees, who are also the directors for the purpose of company law, and who served during the year and up to the date of signature of the financial statements were:

S. Zuckerbrod

L. Hager MBE

A. Tookman

R. Segal

A. Maurice

P. Hertz

L. Shelley

R. Saville

Louise Hager received an MBE in the New Year Honours list for services to People with Cancer

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

Statement of Trustees' responsibilities

The Trustees, who are also the directors of Chai-Lifeline Cancer Care for the purpose of company law, are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company Law requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that year.

In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Going concern

The trustees have considered the charity’s budgets, cash flow forecasts and reserves and consider it appropriate to adopt the going concern basis in preparing the financial statements; no material uncertainties have been identified.

Disclosure of information to auditor

Each of the Trustees has confirmed that there is no information of which they are aware which is relevant to the audit, but of which the auditor is unaware. They have further confirmed that they have taken appropriate steps to identify such relevant information and to establish that the auditor is aware of such information.

This report was approved by the Trustees on 23 December 2025 and signed on their behalf by:

L. Hager MBE Trustee

R. Segal Trustee

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) INDEPENDENT AUDITOR'S REPORT TO THE TRUSTEES OF CHAI-LIFELINE CANCER CARE

Opinion

We have audited the financial statements of Chai-Lifeline Cancer Care (the ‘charity’) for the year ended 31 March 2025 which comprise the statement of financial activities, the balance sheet, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and the provisions available for small entities, in the circumstances set out in note to the financial statements, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the Trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the Trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The Trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters in relation to which the Charities (Accounts and Reports) Regulations 2008 requires us to report to you if, in our opinion:

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF CHAI-LIFELINE CANCER CARE

Responsibilities of Trustees

As explained more fully in the statement of Trustees' responsibilities, the Trustees, who are also the directors of the charity for the purpose of company law, are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the Trustees are responsible for assessing the charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

We have been appointed as auditor under section 144 of the Charities Act 2011 and report in accordance with the Act and relevant regulations made or having effect thereunder.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF CHAI-LIFELINE CANCER CARE

Owing to the inherent limitations of an audit, there is an unavoidable risk that some material misstatements of the financial statements may not be detected, even though the audit is properly planned and performed in accordance with the ISAs (UK).

The potential effects of inherent limitations are particularly significant in the case of misstatement resulting from fraud because fraud may involve sophisticated and carefully organized schemes designed to conceal it, including deliberate failure to record transactions, collusion or intentional misrepresentations being made to us.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https:// www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the charity’s trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. Our audit work has been undertaken so that we might state to the charity’s trustees those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charity and the charity’s trustees as a body, for our audit work, for this report, or for the opinions we have formed.

Landau Morley LLP

24 December 2025

Statutory Auditor Chartered Accountants

325-327 Oldfield Lane North Greenford Middlesex UB6 0FX

Landau Morley LLP is eligible for appointment as auditor of the charity by virtue of its eligibility for appointment as auditor of a company under section 1212 of the Companies Act 2006.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 MARCH 2025

Unrestricted
funds
2025
Notes
£
Income from:
Donations and legacies
3
3,904,880
Investments
4
143,892
Total income
4,048,772
Expenditure on:
Raising funds
5
681,377
Charitable activities
6
3,479,876
Total expenditure
4,161,253
Net gains/(losses) on investments
11
217,225
Net income and movement in funds
104,744
Reconciliation of funds:
Fund balances at 1 April 2024
13,087,751
Fund balances at 31 March 2025
13,192,495		 Restricted
funds
2025
£
105,186
-
105,186
-
72,473
72,473
-
32,713
-
32,713		 Total
Unrestricted
funds
2025
2024
£
£
4,010,066
3,819,861
143,892
186,021
4,153,958
4,005,882
681,377
641,054
3,552,349
3,218,831
4,233,726
3,859,885
217,225
385,778
137,457
531,775
13,087,751
12,555,976
13,225,208
13,087,751		 Total
Unrestricted
funds
2025
2024
£
£
4,010,066
3,819,861
143,892
186,021
4,153,958
4,005,882
681,377
641,054
3,552,349
3,218,831
4,233,726
3,859,885
217,225
385,778
137,457
531,775
13,087,751
12,555,976
13,225,208
13,087,751
4,005,882
641,054
3,218,831
3,859,885
385,778
531,775
12,555,976
13,087,751

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) BALANCE SHEET

AS AT 31 MARCH 2025

Notes
Fixed assets
Tangible assets
13
Investments
14
Current assets
Debtors
16
Investments
17
Cash at bank and in hand
Creditors: amounts falling due within
one year
18
Net current assets
Total assets less current liabilities
Income funds
Restricted funds
20
Unrestricted funds
Designated funds
21
General unrestricted funds		 2025
£
£
4,462,314
4,538,454
9,000,768
293,535
-
4,272,617
4,566,152
(341,712)
4,224,440
13,225,208
32,713
1,000,000
12,192,495
13,192,495
13,225,208		 2024
£
£
4,576,662
6,504,231
11,080,893
306,702
1,250,000
743,610
2,300,312
(293,454)
2,006,858
13,087,751
-
1,000,000
12,087,751
13,087,751
13,087,751		 2024
£
£
4,576,662
6,504,231
11,080,893
306,702
1,250,000
743,610
2,300,312
(293,454)
2,006,858
13,087,751
-
1,000,000
12,087,751
13,087,751
13,087,751
11,080,893
2,006,858
13,087,751
-
13,087,751
13,087,751

The company is entitled to the exemption from the audit requirement contained in section 477 of the Companies Act 2006, for the year ended 31 March 2025, although an audit has been carried out under section 144 of the Charities Act 2011.

The directors acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements under the requirements of the Companies Act 2006, for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Trustees on 23 December 2025

L. Hager MBE R. Segal
Trustee Trustee

Company Registration No. 03640937

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 MARCH 2025

2025 2024
Notes £ £ £ £
Cash flows from operating activities
Cash (absorbed by)/generated from 27
operations (19,114) 71,614
Investing activities
Purchase of tangible fixed assets (28,772) (52,011)
Purchase of investments (5,695,349) (2,301,970)
Proceeds from disposal of investments 9,128,350 488,200
Investment income received 143,892 186,021
Net cash generated from/(used in)
investing activities 3,548,121 (1,679,760)
Net cash used in financing activities - -
Net increase/(decrease) in cash and cash
equivalents 3,529,007 (1,608,146)
Cash and cash equivalents at beginning of year 743,610 2,351,756
Cash and cash equivalents at end of year 4,272,617 743,610

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

1 Accounting policies

Charity information

Chai-Lifeline Cancer Care is a private company limited by guarantee incorporated in England and Wales. The registered office is 325-327 Oldfield Lane North, Greenford, Middlesex, UB6 0FX.

1.1 Basis of preparation

The financial statements have been prepared in accordance with the charity's governing document, the Companies Act 2006 and “Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)” (as amended for accounting periods commencing from 1 January 2019).

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2 Going concern

At the time of approving the financial statements, the Trustees have a reasonable expectation that the Charity has adequate resources to support the current level of expenditure and to continue in operational existence for the foreseeable future.

1.3 Charitable funds

Unrestricted funds are available for use at the discretion of the Trustees in furtherance of their charitable objectives.

Restricted funds are subject to specific conditions by donors or grantors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.

1.4 Income

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

1 Accounting policies

(Continued)

1.5 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.

Fundraising costs are those incurred in seeking voluntary contributions and do not include the costs of disseminating information in support of the charitable activities. Support costs are those costs incurred directly in support of expenditure on the objects of the company and include project management carried out at Headquarters. Governance costs are those incurred in connection with administration of the company and compliance with constitutional and statutory requirements.

Costs of generating funds are costs incurred in attracting voluntary income, and those incurred in trading activities that raise funds.

Charitable activities and Governance costs are costs incurred on the company's educational operations, including support costs and costs relating to the governance of the company apportioned to charitable activities.

1.6 Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold property 2% straight line Office equipment 15% straight line Fixtures and fittings 15% straight line Computer equipment 33% straight line

Freehold land and assets in the course of construction are not depreciated.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.

1.7 Fixed asset investments

Fixed asset investments are initially measured at transaction price excluding transaction costs, and are subsequently measured at fair value at each reporting date. Changes in fair value are recognised in net income/(expenditure) for the year. Transaction costs are expensed as incurred.

A subsidiary is an entity controlled by the charity. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.8 Impairment of fixed assets

At each reporting end date, the charity reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

1 Accounting policies

(Continued)

1.9 Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.10 Financial instruments

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.11 Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.12 Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2 Critical accounting estimates and judgements

In the application of the charity’s accounting policies, the Trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

3 Donations and legacies

Unrestricted
Restricted
funds
funds
2025
2025
£
£
Donations and gifts
General donations
396,827
-
Patronage
63,162
-
Legacies
298,323
-
New Year appeal
178,534
-
Pesach appeal
66,040
-
Golf days
48,826
-
Income from Dinner Function
-
-
Chai Challenge
60,591
-
Ladies Events
-
-
London Marathon
24,201
Manchester Events
14,413
Other fundraising events
354,265
67,927
Service donations
144,537
37,259
Annual Campaigns
2,255,161
-
3,904,880
105,186		 Total
Unrestricted
Restricted
funds
funds
2025
2024
2024
£
£
£
396,827
372,360
-
63,162
49,531
-
298,323
162,562
-
178,534
179,756
-
66,040
82,315
-
48,826
118,324
-
-
3,659
-
60,591
-
-
-
120,819
-
24,201
58,263
-
14,413
5,800
-
422,192
160,204
-
181,796
178,078
-
2,255,161
2,328,190
-
4,010,066
3,819,861
-		 Total
2024
£
372,360
49,531
162,562
179,756
82,315
118,324
3,659
-
120,819
58,263
5,800
160,204
178,078
2,328,190
3,819,861

FOR THE YEAR ENDED 31 MARCH 2025

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

4 Income from investments

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Other income 135,606 170,017
Interest receivable 8,286 16,004
143,892 186,021

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

5 Raising funds

Unrestricted
funds
2025
£
Fundraising and publicity
Fundraising costs
361,987
Staff costs
302,722
Fundraising and publicity
664,709
Investment management
16,668
681,377
Costs of Raising funds comprised:
2025
Fundraising and publicity
General donations
32,364
Patronage
5,151
Legacy costs
3,463
New Year appeal
34,356
Pesach appeal
29,644
Golf days
13,827
Dinner Function
-
Chai Challenge
4,942
Ladies Events
-
London Marathon
6,389
Manchester events
34,773
Other fundraising events
190,758
Services
14,827
Annual Campaigns
294,213
Total
664,707		 Total
2024
£
313,365
309,859
623,224
17,830
641,054
2024
31,548
5,128
3,176
36,940
23,733
30,540
309
-
63,664
8,195
27,627
75,466
15,087
301,811
623,224

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

6 Charitable activities

Staff costs
Freelance therapists' and consultants' costs
Publications costs
Advertising services
Training supervisor costs
Room hire costs
Patients' aids/Consumables
Laundry services
Other costs
Share of support costs (see note 7)
Share of governance costs (see note 7)
Analysis by fund
Unrestricted funds
Restricted funds		 2025
£
1,054,042
1,043,830
155,935
90,377
73,724
78,492
8,169
12,043
129,490
2,646,102
886,628
19,619
3,552,349
3,479,876
72,473
3,552,349		 2024
£
940,049
996,115
165,415
77,571
45,877
68,063
8,460
11,692
132,932
2,446,174
754,556
18,101
3,218,831
3,218,831
-
3,218,831

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

7
Support costs
Staff costs
Depreciation
Premises costs
Rates, water and
electricity
Newspapers and journals
Computer and internet
expenses
Telephone
Other costs
Postage and printing
Legal & Professional fees
Audit fees
Accountancy
Analysed between
Charitable activities		 Support
costs
Governance
costs
£
£
242,852
-
143,121
-
192,990
-
66,323
-
8,691
-
65,144
-
13,952
-
41,035
-
28,970
-
83,550
-
-
13,340
-
6,279
886,628
19,619
886,628
19,619		 2025Support costs Governance
costs
£
£
£
242,852
201,066
-
143,121
153,141
-
192,990
145,462
-
66,323
50,203
-
8,691
7,567
-
65,144
60,178
-
13,952
12,725
-
41,035
42,025
-
28,970
25,543
-
83,550
56,646
-
13,340
-
12,200
6,279
-
5,901
906,247
754,556
18,101
906,247
754,556
18,101		 2024
£
201,066
153,141
145,462
50,203
7,567
60,178
12,725
42,025
25,543
56,646
12,200
5,901
772,657
772,657

Governance costs include payments to the auditors of £13,340 (2024: £12,200) for audit fees and 6,279 (2024: £5,901) for non audit fees.

8 Net movement in funds 2025 2024
£ £
The net movement in funds is stated after charging/(crediting):
Fees payable for the audit of the charity's financial statements 13,340 12,200
Depreciation of owned tangible fixed assets 143,121 153,141

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

9 Employees

Number of employees

The average monthly number of employees during the year was:

Employment costs
Wages and salaries
Social security costs
Other pension costs		 2025
Number
33
2025
£
1,385,191
144,765
69,660
1,599,616		 2024
Number
31
2024
£
1,255,146
130,203
65,625
1,450,974

The key management personnel of the charity comprise one of the Trustees and the Chief Executive. The total employee benefits of the key management personnel of the Charity were £273,602 (2024: £251,993).

Of the employees whose emoluments exceed £60,000, 4 (2024: 2) have retirement benefits accruing under defined contribution pension schemes.

The number of employees whose annual remuneration was £60,000 or more were:

2025 2024
Number Number
In the band £60,001 - £70,000 2 -
In the band £90,001 - £100,000 1 1
In the band £140,001 - £150,000 1 1

10 Trustees' remuneration

The Charity Commission approved payments of remuneration, benefits in kind and pension contributions to Louise Hager, a trustee of the Charity, in her role as Chairman. Louise Hager promotes the charity nationally and internationally and leads the fundraising department. Payments are made pursuant to the authority set out in Article 5 of the Charity's Articles of Association.

Remuneration paid to the trustee (including benefits in kind and pension contributions) during the year ended 31 March 2025 totalled £148,956 (2024: £145,944).

During the year retirement benefits were accruing to 1 Trustee (2024: 1) in respect of defined contribution pension schemes.

No other Trustee received any remuneration or reimbursed expenses in the year.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

11 Gains and losses on investments

Unrestricted Unrestricted
funds funds
2025 2024
Gains/(losses) arising on: £ £
Revaluation of investments 217,225 385,778

12 Taxation

The charity is exempt from tax on income and gains falling within section 505 of the Taxes Act 1988 or section 252 of the Taxation of Chargeable Gains Act 1992 to the extent that these are applied to its charitable objects.

13 Tangible fixed assets

Cost
At 1 April 2024
Additions
At 31 March 2025
Depreciation and impairment
At 1 April 2024
Depreciation charged in the year
At 31 March 2025
Carrying amount
At 31 March 2025
At 31 March 2024		 Freehold
property
£
6,215,608
-
6,215,608
1,733,345
102,712
1,836,057
4,379,551
4,482,263		 Office
equipment
Fixtures and
fittings
£
£
82,617
796,888
-
17,316
82,617
814,204
80,975
720,208
615
22,861
81,590
743,069
1,027
71,135
1,641
76,680		 Computer
equipment
£
276,284
11,456
287,740
260,206
16,933
277,139
10,601
16,078		 Total
£
7,371,397
28,772
7,400,169
2,794,734
143,121
2,937,855
4,462,314
4,576,662

Included in freehold property is land with a historic cost of £1,080,000 (2024: £1,080,000) that is not depreciated.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

14 Fixed asset investments

Listed Other Total
investments investments
£ £ £
Cost or valuation
At 1 April 2024 6,504,229 2 6,504,231
Additions 5,695,349 - 5,695,349
Valuation changes 217,224 - 217,224
Disposals (7,878,350) - (7,878,350)
At 31 March 2025 4,538,452 2 4,538,454
Carrying amount
At 31 March 2025 4,538,452 2 4,538,454
At 31 March 2024 6,504,229 2 6,504,231
2025 2024
Other investments comprise: Notes £ £
Investments in subsidiaries 26 2 2
Fixed asset investments revalued
15 Financial instruments
2025 2024
£ £
Carrying amount of financial assets
Instruments measured at fair value through profit or loss - 1,250,000
Carrying amount of financial liabilities
Measured at fair value through profit or loss
- Other financial liabilities 309,519 259,845
16 Debtors
2025 2024
Amounts falling due within one year: £ £
Income tax recoverable and other debtors 217,862 221,447
Prepayments and accrued income 75,673 85,255
293,535 306,702

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

17 Current asset investments

Unlisted investments

2025 2024
£ £
- 1,250,000

Current asset investment represents the UK and overseas bonds of £nil (2024: £1,250,000) in Israel. The bond will be matured on 01 February 2027, therefore, the current assets investments are classified to fixed assets investments.

18 Creditors: amounts falling due within one year

Other taxation and social security
Trade creditors
Amounts owed to subsidiary undertakings
Accruals and deferred income		 2025
£
32,193
173,400
2
136,117
341,712		 2024
£
33,609
163,989
2
95,854
293,454

Accruals and deferred income include deferred income totaling £89,854 (2024: £66,573) in respect of amounts received in advance.

19 Retirement benefit schemes

Retirement benefit schemes
2025 2024
Defined contribution schemes £ £
Charge to profit or loss in respect of defined contribution schemes 69,660 65,625

The charity operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the charity in an independently administered fund.

20 Restricted funds

Chai Centre - Outpatient Rehabilitation &
Palliative Care
Chai Home Support Services
Chai In Schools
Chai BRCA Gene Testing Programme
Chai Support Groups		 At 1 April
2024
Incoming
resources
Resources
expended
At 31 March
2025
£
£
£
£
-
16,859
16,859
-
-
5,400
5,400
-
-
2,500
2,500
-
-
65,427
32,713
32,713
-
15,000
15,000
-
-
105,186
(72,473)
32,713		 At 1 April
2024
Incoming
resources
Resources
expended
At 31 March
2025
£
£
£
£
-
16,859
16,859
-
-
5,400
5,400
-
-
2,500
2,500
-
-
65,427
32,713
32,713
-
15,000
15,000
-
-
105,186
(72,473)
32,713
32,713

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

20 Restricted funds

(Continued)

The restricted BRCA funds were received in order to provide counselling for individuals, couples and families as well as running BRCA Support groups.

21 Unrestricted funds

The unrestricted funds of the charity comprise the unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes.

Designated fund
General funds
Previous year:
Designated fund
General funds		 At 1 April
2024
£
1,000,000
12,087,751
13,087,751
At 1 April
2023
£
1,000,000
11,555,976
12,555,976		 Incoming
resources
£
-
4,048,772
4,048,772
Incoming
resources
£
-
4,005,882
4,005,882		 Resources
expended
£
-
(4,161,253)
(4,161,253)
Resources
expended
£
-
(3,859,885)
(3,859,885)		 Gains and
losses
At 31 March
2025
£
£
-
1,000,000
217,225
12,192,495
217,225
13,192,495
Gains and
losses
At 31 March
2024
£
£
-
1,000,000
385,778
12,087,751
385,778
13,087,751		 Gains and
losses
At 31 March
2025
£
£
-
1,000,000
217,225
12,192,495
217,225
13,192,495
Gains and
losses
At 31 March
2024
£
£
-
1,000,000
385,778
12,087,751
385,778
13,087,751
13,087,751

Designated funds represent amounts sent aside by the trustees in order to accumulate funds towards a future capital project at the Flagship Centre in NW London.

22 Analysis of net assets between funds

Unrestricted
funds
2025
£
At 31 March 2025:
Tangible assets
4,462,314
Investments
4,538,454
Current assets/(liabilities)
4,191,727
13,192,495		 Restricted
funds
2025
£
-
-
32,713
32,713		 Total
2025
£
4,462,314
4,538,454
4,224,440
13,225,208

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

22 Analysis of net assets between funds

Analysis of net assets between funds
Unrestricted
funds
2024
£
At 31 March 2024:
Tangible assets
4,576,662
Investments
6,504,231
Current assets/(liabilities)
2,006,858
13,087,751		 (Continued)
Restricted
Total
funds
2024
2024
£
£
-
4,576,662
-
6,504,231
-
2,006,858
-
13,087,751		 (Continued)
Restricted
Total
funds
2024
2024
£
£
-
4,576,662
-
6,504,231
-
2,006,858
-
13,087,751
13,087,751

23 Operating lease commitments

Lessee

At the reporting year end date the charity had outstanding commitments for future minimum lease payments under non-cancellable operating leases which fall due as follows:

Within one year
Between two and five years		 2025
£
5,725
2,863
8,588		 2024
£
5,725
14,313
20,038

24 Related party transactions

Donations of £32,472 (2024: £30,873) were received during the year from the Trustees and from entities connected with the Trustees.

25 Controlling Party

The company is limited by guarantee and under the control of the Trustees.

26 Subsidiaries

Details of the charity's subsidiary at 31 March 2025 are as follows:

Name of undertaking Registered Nature of business Class of % Held
office shares held Direct Indirect
Chai-Lifeline Services England & Wales Dormant Ordinary 100.00
Limited

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

26 Subsidiaries

(Continued)

The aggregate capital and reserves and the result for the year of subsidiaries excluded from consolidation was as follows:

Name of undertaking Profit/(Loss) Capital and
Reserves
£ £
Chai-Lifeline Services
Limited 2
27 Cash (absorbed by)/generated from operations 2025 2024
£ £
Surplus for the year 137,457 531,775
Adjustments for:
Investment income recognised in statement of financial activities (143,892) (186,021)
Fair value gains and losses on investments (217,225) (385,778)
Depreciation and impairment of tangible fixed assets 143,121 153,141
Movements in working capital:
Decrease/(increase) in debtors 13,167 (10,411)
Increase/(decrease) in creditors 48,258 (31,092)
Cash (absorbed by)/generated from operations (19,114) 71,614
28 Analysis of changes in net funds

The charity had no material debt during the year.